title: Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline.
abstract: The ion channel probe phencyclidine [1-(1-phenylcyclohexyl)piperidine; PCP] selectively inhibited aggregation, secretion and ultrastructural changes in platelets induced by adrenaline, but did not affect activation induced by other common platelet agonists such as alpha-thrombin, ADP, collagen or ionophore A23187. [3H]PCP bound to platelets with high affinity (Kd 134 +/- 33 nM; 3600 +/- 1020 sites/platelet), as did the thienyl analogue [3H]TCP (1-[1-(2-thienyl)cyclohexyl]piperidine). PCP binding to platelets was increased 3-4-fold in N-methylglucamine buffer in the absence of Na+ ions. Binding was unaffected by haloperidol and was only weakly inhibited (EC50 10-20 microM), without significant stereoselectivity by the two sets of stereoselective ligands, dexoxadrol/levoxadrol and (+)MK801/(-)MK801. Binding of PCP was not competed for by adrenaline or yohimbine. Only the high-affinity binding of [3H]PCP to platelets was blocked by prior treatment of the platelets with the covalent affinity probe Metaphit, and these platelets no longer aggregated in response to adrenaline although they responded normally to alpha-thrombin, ADP and collagen. These results suggest that platelets contain high-affinity receptors for PCP that can modulate adrenaline-induced platelet activation.
authors.affiliation: Cell Biology Laboratory, American Red Cross, Rockville, MD 20855.
authors.forename: G A
authors.initials: GA
authors.lastname: Jamieson
authors.forename: A K
authors.initials: AK
authors.lastname: Agrawal
authors.forename: N J
authors.initials: NJ
authors.lastname: Greco
authors.forename: T E
authors.initials: TE
authors.lastname: Tenner
authors.forename: G D
authors.initials: GD
authors.lastname: Jones
authors.forename: K C
authors.initials: KC
authors.lastname: Rice
authors.forename: A E
authors.initials: AE
authors.lastname: Jacobson
authors.forename: J G
authors.initials: JG
authors.lastname: White
authors.forename: N N
authors.initials: NN
authors.lastname: Tandon
mesh_terms: D001667:Binding, Competitive; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D002478:Cells, Cultured; D002850:Chromatography, Gel; D000242:Cyclic AMP / Q000378:metabolism; D004148:Dioxolanes / Q000494:pharmacology; D016291:Dizocilpine Maleate / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology*; D006801:Humans; D010622:Phencyclidine / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D015539:Platelet Activation / Q000187:drug effects*; D017981:Receptors, Neurotransmitter / Q000037:antagonists & inhibitors / Q000378:metabolism; D017478:Receptors, Phencyclidine
chemical_list: D004148:Dioxolanes; D010880:Piperidines; D017981:Receptors, Neurotransmitter; D017478:Receptors, Phencyclidine; C005840:dioxadrol; D016291:Dizocilpine Maleate; C579649:levoxadrol; C044705:metaphit; D000242:Cyclic AMP; D010622:Phencyclidine; C579650:dexoxadrol; D004837:Epinephrine